Themis Medicare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 12, 2025
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Themis Medicare has informed the exchanges that its 55th Annual General Meeting will be held on Friday, 12th September 2025 at 10:00 AM at the registered office in Vapi, Gujarat. Shareholders will consider adopting FY25 audited financials, re-appointing Dr. Adam Demeter as director, and declaring a dividend for FY ended 31st March 2025. The meeting will also seek approval to appoint Ms. Neha Thakore as Independent Woman Director for 5 years, ratify cost auditor remuneration of Rs. 3 lakh for FY26, appoint SAV & Associates LLP as secretarial auditor for 5 years, and pay commission up to 1% of net profits to non-executive directors. The attached Annual Report shows FY25 revenue at Rs. 405.51 crores (up 6.22% YoY), EBITDA at Rs. 49.05 crores, and PAT at Rs. 29.83 crores, driven by strong formulations, hospital, and trade business growth, though the API segment faced pricing pressure. E-voting window runs from 9th to 11th September 2025, with 5th September 2025 as the cut-off date.
Shareholders should watch for the dividend declaration, which if approved will be paid within 30 days of the AGM. The FY25 results indicate steady growth in core pharma segments but margin pressure in the API business, while board changes are routine governance updates.